STOCK TITAN

Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will present at the RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2021, at 4:15 p.m. ET. This presentation will be streamed live and can be accessed via the company's investor relations page. Following the event, a replay will be available for 90 days. Wave Life Sciences is dedicated to developing innovative genetic medicines to treat severe diseases, utilizing its proprietary discovery platform, PRISM.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer is scheduled to give a presentation at the RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 19, 2021 at 4:15 p.m. ET.

A live webcast of the presentation will be available on the investor relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. A replay of the presentation will be archived and available at that site for 90 days following the event.

About Wave Life Sciences 
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com


FAQ

What event will Wave Life Sciences' CEO present at on May 19, 2021?

Wave Life Sciences' CEO, Paul Bolno, will present at the RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2021.

What is the stock symbol for Wave Life Sciences?

The stock symbol for Wave Life Sciences is WVE.

How can I watch the presentation by Wave Life Sciences' CEO?

You can watch the presentation live on the investor relations page of Wave Life Sciences' website.

Will there be a replay available for the Wave Life Sciences presentation?

Yes, a replay of the presentation will be available for 90 days following the event.

What is the focus of Wave Life Sciences' research and development?

Wave Life Sciences focuses on developing genetic medicines for devastating diseases using their proprietary PRISM platform.

Wave Life Sciences Ltd. Ordinary Shares

NASDAQ:WVE

WVE Rankings

WVE Latest News

WVE Stock Data

2.16B
129.41M
15.04%
78.49%
4.48%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SINGAPORE